| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Park Robert J | SVP & Chief Financial Officer | C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO | /s/ Daniel Rodriguez as Attorney-in-Fact for Robert Park | 16 Oct 2025 | 0001887569 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DLB | Class A Common Stock | Tax liability | $245,479 | -3,552 | -5.1% | $69.11 | 66,085 | 15 Oct 2024 | Direct | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. |
| F2 | Shares held following the reported transactions include 38,186 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. |
| F3 | Shares include 350 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025. |